Stock Track | CVS Health Surges 5.11% Pre-market on Strong Q3 Results and Raised Guidance

Stock Track

Oct 29

CVS Health (NYSE: CVS) stock soared 5.11% in pre-market trading on Wednesday following the release of its third-quarter earnings report, which exceeded analysts' expectations and prompted the company to raise its full-year guidance.

The healthcare giant reported adjusted earnings per share of $1.60 for Q3, significantly beating the Wall Street consensus estimate of $1.37. Total revenue for the quarter climbed 7.8% year-over-year to $102.87 billion, surpassing analysts' projections of $98.85 billion. The strong performance was driven by improved results across its business segments, particularly in the Health Care Benefits division.

In light of the robust quarterly results, CVS Health raised its full-year 2025 adjusted earnings per share guidance to a range of $6.55 to $6.65, up from the previous forecast of $6.30 to $6.40. This upward revision reflects the company's confidence in its ongoing operational improvements and growth strategies. Additionally, CVS updated its cash flow from operations guidance to a range of $7.5 billion to $8.0 billion for the full year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1190623181"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190623181\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190623181?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-29 20:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190623181","market":"sg","top_or_hot":-1,"title":"Stock Track | CVS Health Surges 5.11% Pre-market on Strong Q3 Results and Raised Guidance","media":"Stock Track","content":"<p>CVS Health (NYSE: CVS) stock soared 5.11% in pre-market trading on Wednesday following the release of its third-quarter earnings report, which exceeded analysts' expectations and prompted the company to raise its full-year guidance.</p>\n\n<p>The healthcare giant reported adjusted earnings per share of $1.60 for Q3, significantly beating the Wall Street consensus estimate of $1.37. Total revenue for the quarter climbed 7.8% year-over-year to $102.87 billion, surpassing analysts' projections of $98.85 billion. The strong performance was driven by improved results across its business segments, particularly in the Health Care Benefits division.</p>\n\n<p>In light of the robust quarterly results, CVS Health raised its full-year 2025 adjusted earnings per share guidance to a range of $6.55 to $6.65, up from the previous forecast of $6.30 to $6.40. This upward revision reflects the company's confidence in its ongoing operational improvements and growth strategies. Additionally, CVS updated its cash flow from operations guidance to a range of $7.5 billion to $8.0 billion for the full year.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CVS Health Surges 5.11% Pre-market on Strong Q3 Results and Raised Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CVS Health Surges 5.11% Pre-market on Strong Q3 Results and Raised Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-29 20:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CVS Health (NYSE: CVS) stock soared 5.11% in pre-market trading on Wednesday following the release of its third-quarter earnings report, which exceeded analysts' expectations and prompted the company to raise its full-year guidance.</p>\n\n<p>The healthcare giant reported adjusted earnings per share of $1.60 for Q3, significantly beating the Wall Street consensus estimate of $1.37. Total revenue for the quarter climbed 7.8% year-over-year to $102.87 billion, surpassing analysts' projections of $98.85 billion. The strong performance was driven by improved results across its business segments, particularly in the Health Care Benefits division.</p>\n\n<p>In light of the robust quarterly results, CVS Health raised its full-year 2025 adjusted earnings per share guidance to a range of $6.55 to $6.65, up from the previous forecast of $6.30 to $6.40. This upward revision reflects the company's confidence in its ongoing operational improvements and growth strategies. Additionally, CVS updated its cash flow from operations guidance to a range of $7.5 billion to $8.0 billion for the full year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CVS","symbol_name":"西维斯健康","start_time":0,"source_url":"","article_id":"1190623181","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190623181","pubTimestamp":1761740902,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CVS Health (NYSE: CVS) stock soared 5.11% in pre-market trading on Wednesday following the release of its third-quarter earnings report, which exceeded analysts' expectations and prompted the company...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CVS":"西维斯健康"},"translate_title":"个股追踪|CVS Health盘前大涨5.11%，因第三季度业绩强劲且指引上调","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVS":1},"content_text":"CVS Health (NYSE: CVS) stock soared 5.11% in pre-market trading on Wednesday following the release of its third-quarter earnings report, which exceeded analysts' expectations and prompted the company to raise its full-year guidance.\nThe healthcare giant reported adjusted earnings per share of $1.60 for Q3, significantly beating the Wall Street consensus estimate of $1.37. Total revenue for the quarter climbed 7.8% year-over-year to $102.87 billion, surpassing analysts' projections of $98.85 billion. The strong performance was driven by improved results across its business segments, particularly in the Health Care Benefits division.\nIn light of the robust quarterly results, CVS Health raised its full-year 2025 adjusted earnings per share guidance to a range of $6.55 to $6.65, up from the previous forecast of $6.30 to $6.40. This upward revision reflects the company's confidence in its ongoing operational improvements and growth strategies. Additionally, CVS updated its cash flow from operations guidance to a range of $7.5 billion to $8.0 billion for the full year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}